Perspective Therapeutics Inc CATX

Healthcare Biotechnology

Perspective Therapeutics, Inc. is a radiopharmaceutical development company that is developing advanced treatment applications for cancers throughout the body. The Company has proprietary technology that utilizes the alpha-emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides. It is also developing imaging diagnostics that incorporate the same targeting peptides, which provide the opportunity to personalize treatment and optimize patient outcomes. This theranostic approach enables the ability to see the specific tumor and then treat it to potentially improve efficacy and minimize toxicity. The Company's melanoma (VMT01) and neuroendocrine tumor (VMT-a-NET) programs have entered Phase I/IIa imaging and therapy trials for the treatment of metastatic melanoma and neuroendocrine tumors at several academic institutions. It has also developed a 212Pb generator to secure key isotopes for clinical trial and commercial operations.

NYSEAM:CATX - Post by User

Perspective Therapeutics Inc

Bullboard Posts

Post by kingposton May 25, 2015 7:51pm

489 Views

Post# 23762907

ISR stock monitored by SEC FBI & even White House

Thus is according to a yahoo poster....very entertaining post at Yahoo ISR message board... Celebrity Jim Cramer and Adam Feurstein accused of massive criminal enterprise worldwide...I am sure this will be made into a movie....up to a dozen law. Firms already looking into both sides. .

Bullboard Posts

Canadian government to fund Electric Royalties portfolio property